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Abstract 
BACKGROUND: White coat hypertension (WCH) is described as an anxiety-provoked, 
elevated in-office blood pressure reading, combined with a normal blood pressure reading 
outside of the clinic setting.  This condition is often misdiagnosed as hypertension and can result 
in  unnecessary antihypertensive treatment. PURPOSE: The purpose of this project was to 
determine provider adherence to the 2017 American College of Cardiology/American Heart 
Association hypertension guidelines for appropriate diagnosis and treatment of patients with 
white coat hypertension. METHODS:  A retrospective chart review was performed on 100 
randomly selected medical records of patients from an urban primary care practice diagnosed 
with an elevated blood pressure from January 1, 2018 to November 30, 2018. The use of blood 
pressure logs was evaluated before a diagnosis of hypertension was made. Overall blood pressure 
management was also evaluated. RESULTS: In this sample blood pressure logs were requested 
50% of the time and 24% were then diagnosed with hypertension.  Of the 24% of  patients who 
were diagnosed with hypertension, no logs were used for the diagnosis. Medication was 
prescribed in 13% who had an elevated blood pressure without a diagnosis of hypertension.  
Nonpharmacologic management was documented in 56% of the sample. CONCLUSION: In this 
study, providers did not consistently adhere to the guideline for prescribing antihypertensive 
medication and nonpharmacologic management for elevated blood pressure. Findings did not 
indicate that home blood pressure monitoring was used for decision-making related to white coat 
hypertension. Home blood pressure monitoring is underutilized, and medications may be 
prescribed unnecessarily. 
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Evaluation of Provider Use of the 2017 American College of Cardiology/American Heart 
Association Guidelines for Diagnosis and Management of White Coat Hypertension 
Introduction 
 White coat hypertension (WCH), also referred to as white coat syndrome, affects 
approximately one-third of the adult population (Cobos, Haskard-Zolnierek, & Howard, 2015). It 
is best described as an anxiety-provoked, elevated in-office blood pressure reading, combined 
with a normal blood pressure reading outside of the clinic setting (Cobos, Haskard-Zolnierek, & 
Howard, 2015).   When this condition is misdiagnosed as hypertension, it results in subsequent 
prescribing of unnecessary antihypertensives (Donofrio Angelucci, 2012; Grossman, 2013).  The 
use of home blood pressure monitoring (HBPM) to correctly identify WCH can prevent 
unnecessary medication prescribing, as well as a foreseeable 14% reduction in medical costs 
(Whelton et al., 2017). The purpose of this project was to determine if providers were following 
the 2017 American College of Cardiology/American Heart Association (ACC/AHA) 
hypertension guidelines, for appropriate diagnosis and treatment of patients with WCH. 
Background 
     WCH is defined as an elevated in-office blood pressure reading that exceeds 130/80 mmHg, 
but less than 160/100 mmHg. It is accompanied by ambulatory blood pressure readings of less 
than 130/80 mmHg (Whelton, et al., 2017). Approximately 33% of adult patients have WCH 
(Cobos, Haskard-Zolnierek, & Howard, 2015). This can result  in prescribing unnecessary 
antihypertensive medications which can cause hypotension, syncopal episodes, falls, as well as 
the risk of medication side effects (Whelton et al., 2017).   This condition can be correctly 
identified through either ambulatory blood pressure monitoring (ABPM) or HBPM. This can 
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prevent unnecessary medication prescribing and reduce medical costs by 14%. Not only are costs 
to the healthcare system decreased but blood pressure values from the home setting may result in 
fewer visits to the provider, a cost savings for those with high deductibles (Wang et al., 2013). 
        ABPM is defined as an electronic blood pressure monitoring device that the patient wears to 
measure blood pressure at designated intervals during daily activities and at rest (CDC, 2017; 
Whelton et al., 2017).  Home blood pressure monitoring, also known as self-measured blood 
pressure monitoring, is defined as a blood pressure reading which is taken at home or elsewhere 
outside of the clinic setting. While ABPM is considered the best out of office measurement, 
HPBM is a more practical method (CDC, 2017; Whelton et al., 2017). The anticipated success of 
HBPM is to capture an accurate blood pressure that is not falsely elevated, and to thus properly 
identify normotensive versus hypertensive patients. The benefit of HBPM is that the patient is in 
a less tense and more comfortable environment, allowing a more accurate blood pressure reading 
to be captured (Donofrio Angelucci, 2012). 
 The success of home blood pressure monitoring is integral in determining white coat 
hypertension. Patients need to be instructed on how and when to record a home blood pressure. 
Using the CDC, 2017 recommendations patients should take their blood pressure at the same 
time every day with feet flat on the floor. Additionally, the arm should be at heart level with an 
adequately sized cuff (CDC, 2017).  
 Home blood pressure monitoring documented in a patient-kept blood pressure log has 
been shown to properly identify white coat syndrome. Readings outside an office setting allow 
for a less stressful physiological response (Whelton et al., 2017). Patient-kept blood pressure logs 
detailing their home blood pressure readings have also been shown to be a more reliable 
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indicator of cardiovascular outcomes (Wang et al., 2013). To date, no other reliable screening 
tool exists to accurately identify white coat syndrome (Piper, Evans, Burda, et al., 2014).  
 For providers, a number of options can be used to document the patients home blood 
pressure readings. There is now technology available for providers to upload patients home 
blood pressure logs into an electronic health record for their review. If this is not available, 
providers can simply document a patient’s home blood pressures in a communication  encounter 
via an email, telephone call, or through the electronic health record.  
Purpose and Objectives 
     The purpose of this project was to determine if providers were following the 2017 ACC/AHA 
hypertension guidelines, for appropriate diagnosis and treatment of patients with WCH. More 
specifically, this project aimed to determine the percentage of: 
1. Patients with an elevated blood pressure diagnosis that were instructed to complete a 
home blood pressure log documented in the electronic health record, 
2. Patients with an elevated blood pressure diagnosis who had completed home blood 
pressure logs on a subsequent encounter  
3. Primary care providers who used home blood pressure logs for prescribing an 
antihypertensive, and  
4. Providers who followed the 2017 ACC/AHA guidelines for the appropriate diagnosis and 
management of hypertension. 
Methods 
 The setting of this project was in a large Kentucky urban healthcare organization where 
there are multiple primary care practices. The population that is served within the primary care 
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clinics is across the lifespan with varying disease processes and diagnoses. For this project, only 
adults were included and subsequently receiving care at any one of the primary care practices.  A 
retrospective design was used to determine provider adherence to the ACC/AHA 2017 
hypertension guidelines for appropriate diagnosis and treatment of patients with WCH.   
Sample 
 The inclusion criteria for the sample were: 1) all patients over the age of 18 years, 2) 
established patients in one of the primary care clinics, 3) a blood pressure reading greater than or 
equal to 130/80, 4) a diagnosis of an elevated blood pressure reading without a diagnosis of 
hypertension, and 5) an encounter in one of the clinics between January 1, 2018 and November 
30, 2018.  The ICD-10 diagnostic code for an elevated blood pressure without a diagnosis of 
hypertension is R03 and was used as a proxy for a diagnosis of WCH. Exclusion criteria for the 
sample consisted of an existing hypertension diagnosis, not seen within the past 6 months at the 
primary care clinic, presence of chronic kidney disease, and presence of congestive heart failure. 
 A total of  51,000 patients were identified from the healthcare system as having any 
diagnosis of elevated blood pressures which included hypertension. From that list, 100 charts 
were randomly selected that met the inclusion criteria  with the diagnostic code of R03.  Charts 
were reviewed for the following: a) documentation in the plan that the provider requested the 
patient keep a blood pressure log, b)  documentation that a patient-kept home blood pressure log 
was kept, c) documentation that the log was used in a subsequent visit to determine hypertension, 
d) documentation of pharmacological and nonpharmacological measures per the 2017 
ACC/AHA guidelines. Data were also collected on demographics of age, gender and race. 
 
WHITE COAT HYPERTENSION IN THE PRIMARY CARE SETTING                                     
8 
 
Informed Consent 
A waiver of informed consent was requested from the University of Kentucky Institutional 
Review Board as there was minimal risk and no direct contact with patients.  The waiver was 
approved by the University of Kentucky Institutional Review Board. The evaluation was 
reviewed and approved by  the healthcare organization’s office of research.  
Procedures 
    The healthcare organization’s information technology department assisted in retrieval of 
electronic health records from the EPIC electronic health record software. The first encounter 
where the diagnosis of elevated blood pressure without a diagnosis of hypertension was the 
starting point for the chart review. One subsequent visit was then explored to evaluate how blood 
pressure logs were used to diagnose hypertension. If there was no subsequent visit the chart was 
examined for follow-up of those who were instructed to keep a blood pressure log.  The collected 
data was stored on a secure and encrypted H drive. The computer storing the collected data was 
password protected, which ensured patient confidentiality.  
Data Analysis 
 Descriptive statistics were used to describe the demographics of the sample.   Frequencies 
were used to determine whether 1) there was documentation in the plan that a blood pressure log 
had been requested, 2) a blood pressure log was uploaded in the electronic health record, 3) a 
diagnosis of hypertension was documented at a subsequent visit 4) a follow-up blood pressure 
reading occurred after the initial elevated blood pressure encounter and 5) an antihypertensive 
medication was prescribed for patients with a diagnosis of elevated blood pressure without a 
diagnosis of hypertension, (R03).  
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Results 
 A total of 100 medical records  were randomly selected from a total of 51,000 patients 
with either a diagnosis of hypertension or an elevated blood pressure without a diagnosis of 
hypertension. The majority of patients in the sample were female (53%) and 84% were over the 
age of 35. Those aged 55 or older encompassed 24% of the sample.  Over half were Caucasian 
(58%) and almost a fourth (24%) were African American (see Table1).    
 The diagnosis of an elevated blood pressure without a diagnosis of hypertension was 
recorded in 76% of the sample and 24% were diagnosed with hypertension at the initial visit.  
Providers documented that a blood pressure log was requested in 55% of those who had a 
diagnosis of an elevated blood pressure without a diagnosis of hypertension. Since 24% were 
seen later in the chart review time frame, no subsequent visits were evaluated for those patients. 
A few patients (3%) did not keep their follow-up appointment.  Among those who had a 
subsequent visit (73%) and were instructed to keep the log, only one-third had documentation of 
HBPM log in the EHR.  
 At the initial visit, blood pressure medication was prescribed for 3% of those with an 
elevated blood pressure who had a reading greater than 160/100 mmHg. Antihypertensive 
medication was prescribed to 10% who were diagnosed with an elevated blood pressure without 
a diagnosis of hypertension (R03) at the initial visit. Their blood pressure readings were greater 
than 130/80 but less than 160/100 mmHg. Those who had a subsequent visit (n=73), 61% did not 
have an elevated blood pressure above 130/80 mmHg from either the blood pressure log or the 
in-office reading. The HBPM confirmed a normal pressure for 88% of those who kept the log.  
 Those who were assigned a diagnosis of hypertension (24%), versus an elevated blood 
pressure reading without a diagnosis of hypertension, all had a follow-up appointment within the 
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study period. There were no requests for HBPM within this group. Approximately half were 
prescribed (n=10) an antihypertensive medication despite  blood pressures that were less than 
160/100. The remaining patients (n=14) who were given the diagnosis of hypertension were 
instructed by the provider to implement nonpharmacological interventions as an attempt to lower 
blood pressure.  
Nonpharmacologic management for blood pressure was documented at the first visit for 
approximately 65% of the total sample.  The most common recommendations were for weight 
loss, adhering to the DASH diet, increasing physical activity, and decreasing or stopping alcohol 
intake. This was documented through the use of an electronic handout that is printed out and 
given upon discharge of the patient. 
Discussion 
 A retrospective chart review was performed to determine provider adherence to the 2017 
ACC/AHA hypertension guidelines for appropriate diagnosis and treatment of patients with 
WCH. WCH is a common problem amongst those in the middle age group which was reflected 
in the sample. The frequency of WCH hypertension increases with age and is most common in 
middle-aged and older adults.(Cobos, Haskard-Zolnierek, & Howard, 2015).  In this sample 
group ethnicity was not reflective of the epidemiology of the disease, however there was no 
attempt to compare ethnic groups. Aronow et al, (2019) described the demographic findings of 
the Dallas Study as such: 63% of the WCH population and 69% of the hypertension population 
were black. 
  In this project, providers adhered to the guideline in over half of the patients initially 
seen with an elevated blood pressure.  Though HBPM readings were not uniformly requested by 
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the providers the majority (73%) had a follow-up appointment and were treated appropriately 
according to the guideline recommendations  based upon either the blood pressure log or the in-
office reading.  Blood pressure logs, when used, did confirm WCH. These findings are similar to 
Burnier and Eganfrom (2019) who found hypertension and WCH was treated appropriately 70% 
of the time.  
 It is unclear why blood pressure logs were not requested by the providers. Reasons 
identified in the literature for not using HBPM include concern about the accuracy of the blood 
pressure measurement, as well as the cost incurred to the patient (George, & McDonald, 2015) 
Yet Whelton et al. (2017) state that the HBPM reading mirrors the in-office reading and 
insurance companies will pay for a cuff. In addition, there are readily available community 
resources were blood pressures can be obtained such as pharmacies, and fire stations. Further, 
providers may be hesitant as they feel it will be an additional burden placed on the patient or they 
don’t feel that patients will comply. 
 Nonpharmacologic interventions are supported by the guideline. The ACC/AHA 
guideline recommends a three-month trial of lifestyle modification and ABPM or HBPM with 
follow-up before prescribing medications (Whelton et al., 2017).  In two-thirds of the sample the 
providers did document lifestyle interventions to control blood pressure. Support from the EHR 
that details lifestyle behaviors that contribute to hypertension is readily available. Though the 
EHR provides access to patient education, it is unclear whether the education is patient specific, 
or the amount of attention and emphasis is placed on lifestyle. This may explain in part why one-
third of the providers did not include patient education. The other consideration is that it was 
discussed but not documented.  
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 Providers often underutilized the many capabilities imbedded within the EHR. For 
example, the system may offer an alert that the blood pressure reading is elevated and link the 
provider to the appropriate management guideline. The EHR could also be used to alert staff for  
follow-up on those patients requested to complete HBPM. In this project, one-third of the 
patients who were instructed to complete HBPM did not have follow-up documentation of its 
completion. This could have been just a documentation issue. Liability for lack of follow-up on 
an elevated blood pressure reading cannot be minimized. Patient’s may be unsure of what all 
HBPM entails and the provider is responsible for providing the necessary information from a 
liability standpoint (Shore, 2007). 
Limitations  
 There are several limitations noted in this project. The sample size was small and without 
meaningful diversity. An additional limitation is that the RO3 proxy code was not uniformly 
utilized and therefore patients were missed who could have met the inclusion criteria. Neither 
providers’ nor patients’ input was solicited. They could have provided insight on the burden of 
completing HBPM. Since 24 patients were seen later in the chart review time frame, no 
subsequent visits were evaluated. In addition, the guidelines being relatively new may not have 
been adopted by the providers which would have been forthcoming in a provider interview. 
  Implications for Practice 
 The use of electronic health record alerts can improve adherence to guidelines (Sroujieh, 
Monroy, & Warren, 2016). An alert can serve as a prompt to the provider regarding new 
evidence-based guidelines such as ordering ABPM or HBPM. The EHR could also be used to 
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improve communication with patients to remind or follow-up on the for HBPM.  Providers need 
continuous in-services on the EMR capabilities, including how to upload a patient log. 
 Providers may find patients are unaware of community resources for blood pressure 
readings.  A simple list could be constructed and given to the patient detailing where community 
blood pressures are available. For those who have a home blood pressure cuff, it would be 
helpful if patients brought the HBPM device and their readings to the office for verification of 
their technique.  
 Finally, most important, providers need to be made aware of the 2017 guidelines with 
appropriate follow-up on their adherence. The role of the medical assistant could be used to 
assist providers in identifying WCH. It would be helpful to standardize how patients are being 
roomed with a trigger to repeat blood pressures if they are elevated. 
Implications for education and further study 
 It would be important to do a needs assessment to determine provider knowledge of the 
2017 ACC/AHA blood pressure guidelines with a larger sample size. If providers are not aware 
of the revisions regarding WCH treatment, this could be an opportunity to provide education on 
the details of the guidelines. Patients also need education on the new recommendations for blood 
pressure management. Many may still think that a reading of 140/90 mmHg is the treatment 
goal, which does not match that of the 2017 guidelines.  
Conclusion 
 In this study, providers did not consistently adhere to the 2017 ACC/AHA guideline for 
the diagnosis and treatment of WCH. Findings did not indicate that home blood pressure 
monitoring was used for decision-making related to white coat hypertension. In today’s 
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healthcare environment every opportunity must be made to encourage patient’s involvement in 
their overall health. Encouraging patients to monitor their home blood pressure may engage them 
in taking an active role. Providers should stay apprised of ACC/AHA guidelines and use EHR’s 
to their full potential in order to provide appropriate management of WCH. 
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Table 1. Demographics (N=100) 
 
Demographics Frequency Percentage 
Gender  
   Male 
   Female 
 
                        47 
                        53 
 
                     47% 
                     53% 
Age  
   18-24 
   25-34 
   35-44 
   45-54 
   55-65 
      >65 
 
                         6 
                         10 
                         13 
                         15 
                         24 
                         32 
 
                       6% 
                     10% 
                     13% 
                     15% 
                     24% 
                     32%     
Race 
   American Indian 
   Asian   
   Black  
   Hispanic 
   White 
    
 
 
                         1 
                         6 
                         24 
                         11 
                         58 
                           
 
                       1% 
                        6% 
                       24% 
                       11% 
                       58%                     
 
Table 2. Visit characteristics following initial elevated BP reading encounter (N =100 ) 
Characteristics Frequency Percentage 
Blood pressure log requested 
   Yes 
   No 
 
55 
45 
 
55% 
45% 
Blood pressure log uploaded 
   Yes 
   No 
 
34 
66 
 
 
34% 
66% 
Follow-up blood pressure 
reading  
   Yes 
   No 
 
55 
45 
 
55% 
45% 
Hypertension Diagnosis 
   Yes 
   No 
 
 
24 
76 
 
 
24% 
76% 
Medication Prescribed 
   Yes 
   No 
 
13 
87 
 
13% 
87% 
Guidelines Adherence 
   Yes 
   No 
 
58 
42 
 
58% 
42% 
 
